{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:54:01Z","timestamp":1791932041743,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1208\/s12249-016-0477-3","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T19:44:14Z","timestamp":1453751054000},"page":"1421-1427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Development and Characterization of Nisin Nanoparticles as Potential Alternative for the Recurrent Vaginal Candidiasis Treatment"],"prefix":"10.1208","volume":"17","author":[{"given":"Let\u00edcia Coli Louvisse","family":"de Abreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Todaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio Cunha","family":"Sathler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Cl\u00e1udio Rodrigues Pereira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Almada","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleonice Marques","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Keiko","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Carla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Pereira","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"477_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.idc.2010.11.003","volume":"25","author":"GJ Alangaden","year":"2011","unstructured":"Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin N Am. 2011;25:201\u201325.","journal-title":"Infect Dis Clin N Am"},{"key":"477_CR2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","volume":"3","author":"P Eggimann","year":"2003","unstructured":"Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill nonimmunosuppressed patients. Lancet Infect Dis. 2003;3:685\u2013702.","journal-title":"Lancet Infect Dis"},{"key":"477_CR3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.archoralbio.2014.05.007","volume":"59","author":"JAdR Curvelo","year":"2014","unstructured":"Curvelo JAdR, Barreto ALS, Portela MB, Alviano DS, Holandino C, Souto-Padr\u00f3n T, et al. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? Arch Oral Biol. 2014;59:928\u201337.","journal-title":"Arch Oral Biol"},{"key":"477_CR4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/03639040903384729","volume":"36","author":"MMGB Aguiar de","year":"2010","unstructured":"de Aguiar MMGB, de Albuquerque RP, Marinho DS, Braga BRS, Dornelas CB, Oliveira A, et al. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. Drug Dev Ind Pharm. 2010;36:594\u2013600.","journal-title":"Drug Dev Ind Pharm"},{"key":"477_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","volume":"25","author":"A Espinel-Ingroff","year":"2008","unstructured":"Espinel-Ingroff A. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol. 2008;25:101\u20136.","journal-title":"Rev Iberoam Micol"},{"key":"477_CR6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1365-2672.2008.03908.x","volume":"105","author":"C Lay Le","year":"2008","unstructured":"Le Lay C, Akerey B, Fliss I, Subirade M, Rouabhia M. Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form. J Appl Microbiol. 2008;105:1630\u20139.","journal-title":"J Appl Microbiol"},{"key":"477_CR7","first-page":"322","volume":"11","author":"M Nascimento","year":"2008","unstructured":"Nascimento M, Finatti D, Moreno I, Kuaye A. Atividade antimicrobiana de Lactococcus lactis subsp. lactis ATCC 11454 produtor de nisina sobre pat\u00f3genos gram-positivos. Braz J Food Technol. 2008;11:322\u20138.","journal-title":"Braz J Food Technol"},{"key":"477_CR8","doi-asserted-by":"crossref","first-page":"e102246","DOI":"10.1371\/journal.pone.0102246","volume":"9","author":"Z AlKhatib","year":"2014","unstructured":"AlKhatib Z, Lagedroste M, Fey I, Kleinschrodt D, Abts A, Smits SHJ. Lantibiotic immunity: inhibition of nisin mediated pore formation by NisI. PLoS One. 2014;9:e102246.","journal-title":"PLoS One"},{"key":"477_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2005.06.004","volume":"1","author":"OM Koo","year":"2005","unstructured":"Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed Nanotechnol Biol Med. 2005;1:193\u2013212.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"477_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clay.2006.06.015","volume":"36","author":"C Aguzzi","year":"2007","unstructured":"Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36:22\u201336.","journal-title":"Appl Clay Sci"},{"key":"477_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4314\/tjpr.v5i1.14634","volume":"5","author":"VJ Mohanraj","year":"2007","unstructured":"Mohanraj VJ, Chen Y. Nanoparticles\u2014a review. Trop J Pharm Res. 2007;5:561\u201373.","journal-title":"Trop J Pharm Res"},{"key":"477_CR12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.msec.2010.02.012","volume":"30","author":"K Fukushima","year":"2010","unstructured":"Fukushima K, Abbate C, Tabuani D, Gennari M, Rizzarelli P, Camino G. Biodegradation trend of poly (\u03b5-caprolactone) and nanocomposites. Mater Sci Eng C. 2010;30:566\u201374.","journal-title":"Mater Sci Eng C"},{"key":"477_CR13","unstructured":"Jelvehgari M, Barar J, Valizadeh H, Heidari N. Preparation and evaluation of poly (\u03f5-caprolactone) nanoparticles-in-microparticles by W\/O\/W emulsion method. Iran J Basic Med Sci. 2010; 13."},{"key":"477_CR14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.radphyschem.2011.02.019","volume":"80","author":"M Zabska","year":"2011","unstructured":"Zabska M, Jaskiewicz K, Kiersnowski A, Szustakiewicz K, Rathgeber S, Piglowski J. Spontaneous exfoliation and self-assembly phenomena in polyvinylpyrrolidone\/synthetic layered silicate nanocomposites. Radiat Phys Chem. 2011;80:1125\u20138.","journal-title":"Radiat Phys Chem"},{"key":"477_CR15","volume-title":"Polymer nanocomposites: processing, characterization, and applications","author":"J Koo","year":"2006","unstructured":"Koo J. Polymer nanocomposites: processing, characterization, and applications. 1st ed. New York: McGraw-Hill Professional; 2006.","edition":"1"},{"key":"477_CR16","first-page":"2581","volume":"6","author":"CG Pupe","year":"2011","unstructured":"Pupe CG, Villardi M, Rodrigues CR, Rocha HVA, Maia LC, de Sousa VP, et al. Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans. Int J Nanomedicine. 2011;6:2581.","journal-title":"Int J Nanomedicine"},{"key":"477_CR17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.44.7.1803-1808.2000","volume":"44","author":"DA Mosca","year":"2000","unstructured":"Mosca DA, Hurst MA, So W, Viajar BS, Fujii CA, Falla TJ. IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob Agents Chemother. 2000;44:1803\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"477_CR18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.thromres.2014.05.009","volume":"134","author":"PC Sathler","year":"2014","unstructured":"Sathler PC, Louren\u00e7o AL, Rodrigues CR, da Silva LCRP, Cabral LM, Jord\u00e3o AK, et al. In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems. Thromb Res. 2014;134:376\u201383.","journal-title":"Thromb Res"},{"key":"477_CR19","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/mp400154a","volume":"10","author":"S Modi","year":"2013","unstructured":"Modi S, Anderson BD. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method. Mol Pharm. 2013;10:3076\u201389.","journal-title":"Mol Pharm"},{"key":"477_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","volume":"52","author":"K Moser","year":"2001","unstructured":"Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52:103\u201312.","journal-title":"Eur J Pharm Biopharm"},{"key":"477_CR21","first-page":"227","volume":"6","author":"M Volta Soares da","year":"2011","unstructured":"da Volta Soares M, Oliveira MR, Dos Santos EP, de Brito Gitirana L, Barbosa GM, Quaresma CH, et al. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells. Int J Nanomed. 2011;6:227\u201338.","journal-title":"Int J Nanomed"},{"key":"477_CR22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jconrel.2012.05.003","volume":"161","author":"DHP Ossa de la","year":"2012","unstructured":"de la Ossa DHP, Ligresti A, Gil-Alegre ME, Aberturas MR, Molpeceres J, Di Marzo V, et al. Poly-\u03b5-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy. J Control Release. 2012;161:927\u201332.","journal-title":"J Control Release"},{"key":"477_CR23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1166\/jbn.2013.1607","volume":"9","author":"TM Araujo de","year":"2013","unstructured":"de Araujo TM, Teixeira Z, Barbosa-Sampaio HC, Rezende LF, Boschero AC, Duran N, et al. Insulin-loaded poly (\u03b5-Caprolactone) nanoparticles: efficient, sustained and safe insulin delivery system. J Biomed Nanotechnol. 2013;9:1098\u2013106.","journal-title":"J Biomed Nanotechnol"},{"key":"477_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2004.09.003","volume":"287","author":"S Salmaso","year":"2004","unstructured":"Salmaso S, Elvassore N, Bertucco A, Lante A, Caliceti P. Nisin-loaded poly-L-lactide nanoparticles produced by CO 2 anti-solvent precipitation for sustained antimicrobial activity. Int J Pharm. 2004;287:163\u201373.","journal-title":"Int J Pharm"},{"key":"477_CR25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.foodcont.2011.09.025","volume":"24","author":"P Prombutara","year":"2012","unstructured":"Prombutara P, Kulwatthanasal Y, Supaka N, Sramala I, Chareonpornwattana S. Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity. Food Control. 2012;24:184\u201390.","journal-title":"Food Control"},{"key":"477_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jfoodeng.2011.04.009","volume":"106","author":"D Xiao","year":"2011","unstructured":"Xiao D, Zhong Q. In vitro release kinetics of nisin as affected by Tween 20 and glycerol coencapsulated in spray-dried zein capsules. J Food Eng. 2011;106:65\u201373.","journal-title":"J Food Eng"},{"key":"477_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.01.021","volume":"94","author":"LH Guerreiro","year":"2012","unstructured":"Guerreiro LH, Da Silva D, Ricci-Junior E, Girard-Dias W, Mascarenhas CM, Sola-Penna M, et al. Polymeric particles for the controlled release of human amylin. Colloids Surf B: Biointerfaces. 2012;94:101\u20136.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"477_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.colsurfb.2014.01.037","volume":"117","author":"\u00d6 Erdemli","year":"2014","unstructured":"Erdemli \u00d6, Usanmaz A, Keskin D, Tezcaner A. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G. Colloids Surf B: Biointerfaces. 2014;117:487\u201396.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"477_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","volume":"192","author":"M Yang","year":"2014","unstructured":"Yang M, Lai SK, Yu T, Wang Y-Y, Happe C, Zhong W, et al. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol. J Control Release Off J Control Release Soc. 2014;192:202\u20138.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"477_CR30","first-page":"29","volume":"50","author":"\u017d Vani\u0107","year":"2013","unstructured":"Vani\u0107 \u017d, \u0160kalko-Basnet N. Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2013;50:29\u201341.","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"477_CR31","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp4002365","volume":"10","author":"J Neves das","year":"2013","unstructured":"das Neves J, Ara\u00fajo F, Andrade F, Michiels J, Ari\u00ebn KK, Vanham G, et al. In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine. Mol Pharm. 2013;10:2793\u2013807.","journal-title":"Mol Pharm"},{"key":"477_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","volume":"3","author":"J Neves das","year":"2011","unstructured":"das Neves J, Amiji M, Sarmento B. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:389\u201399.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"477_CR33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","volume":"107","author":"SK Lai","year":"2010","unstructured":"Lai SK, Wang Y-Y, Hida K, Cone R, Hanes J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A. 2010;107:598\u2013603.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"477_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2010.10.032","volume":"403","author":"J-W Yoo","year":"2011","unstructured":"Yoo J-W, Giri N, Lee CH. pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharm. 2011;403:262\u20137.","journal-title":"Int J Pharm"},{"key":"477_CR35","first-page":"431","volume":"8","author":"AF Ribeiro","year":"2013","unstructured":"Ribeiro AF, de Oliveira Rezende RL, Cabral LM, de Sousa VP. Poly \u03b5-caprolactone nanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box-Behnken design. Int J Nanomedicine. 2013;8:431.","journal-title":"Int J Nanomedicine"},{"key":"477_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.12.035","volume":"352","author":"AF Ourique","year":"2008","unstructured":"Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int J Pharm. 2008;352:1\u20134.","journal-title":"Int J Pharm"},{"key":"477_CR37","first-page":"40","volume":"1","author":"A Mukerjee","year":"2007","unstructured":"Mukerjee A, Sinha VR, Pruthi V. Preparation and characterization of poly-\u03b5-caprolactone particles for controlled insulin delivery. J Biomed Pharm Eng. 2007;1:40\u20134.","journal-title":"J Biomed Pharm Eng"},{"key":"477_CR38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jbm.b.31464","volume":"91","author":"W Xue","year":"2009","unstructured":"Xue W, Bandyopadhyay A, Bose S. Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. J Biomed Mater Res B Appl Biomater. 2009;91:831\u20138.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"477_CR39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1745-7270.2007.00320.x","volume":"39","author":"J Kong","year":"2007","unstructured":"Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin. 2007;39:549\u201359.","journal-title":"Acta Biochim Biophys Sin"},{"key":"477_CR40","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbabio.2007.06.004","volume":"1767","author":"A Barth","year":"2007","unstructured":"Barth A. Infrared spectroscopy of proteins. Biochim Biophys Acta Bioenerg. 2007;1767:1073\u2013101.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"477_CR41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.msec.2012.12.015","volume":"33","author":"S Gautam","year":"2013","unstructured":"Gautam S, Dinda AK, Mishra NC. Fabrication and characterization of PCL\/gelatin composite nanofibrous scaffold for tissue engineering applications by electrospinning method. Mater Sci Eng C. 2013;33:1228\u201335.","journal-title":"Mater Sci Eng C"},{"key":"477_CR42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2009.03.012","volume":"80","author":"SM Gupta","year":"2009","unstructured":"Gupta SM, Aranha CC, Bellare JR, Reddy KVR. Interaction of contraceptive antimicrobial peptide nisin with target cell membranes: implications for use as vaginal microbicide. Contraception. 2009;80:299\u2013307.","journal-title":"Contraception"},{"key":"477_CR43","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1365-2672.2009.04312.x","volume":"107","author":"B Akerey","year":"2009","unstructured":"Akerey B, Le-Lay C, Fliss I, Subirade M, Rouabhia M. In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells. J Appl Microbiol. 2009;107:1298\u2013307.","journal-title":"J Appl Microbiol"},{"key":"477_CR44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/AEM.62.2.456-460.1996","volume":"62","author":"CA Murphy","year":"1996","unstructured":"Murphy CA, Cameron JA, Huang SJ, Vinopal RT. Fusarium polycaprolactone depolymerase is cutinase. Appl Environ Microbiol. 1996;62:456\u201360.","journal-title":"Appl Environ Microbiol"},{"key":"477_CR45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2191-0855-3-8","volume":"3","author":"T-K Chua","year":"2013","unstructured":"Chua T-K, Tseng M, Yang M-K. Degradation of Poly (\u03b5-caprolactone) by thermophilic Streptomyces thermoviolaceus subsp. thermoviolaceus 76T-2. AMB Expr. 2013;3:8.","journal-title":"AMB Expr"},{"key":"477_CR46","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217\u201323.","journal-title":"Acta Pol Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0477-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-016-0477-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0477-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0477-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T10:42:12Z","timestamp":1600080132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-016-0477-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1208\/s12249-016-0477-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}